WHO Reports Low Global Flu Activity, but H1N1 Dominates in Some Regions

WHO Reports Low Global Flu Activity, but H1N1 Dominates in Some Regions

Rating
—/5 0 ratings
Follow us on Google News
Health & Lifestyle7 min read

Globally, influenza was circulating at a low level in data published by the World Health Organization (WHO) on 14 October 2026: the proportion of positive samples was below 10%. The same report shows, however, that the picture is not uniform. Higher levels were reported in certain countries and regions, and influenza A(H1N1)pdm09 predominated in several of those areas.

For Romania, the useful conclusion is not that “H1N1 has arrived” or that the season is already severe. Global, European and national data measure different things. Romania’s National Institute of Public Health (INSP) report for 5–11 October recorded 12 laboratory-confirmed influenza cases, 201 cases of clinical influenza and the season’s first death confirmed with an influenza virus, but it does not yet allow an assessment of the scale or severity of the 2026–2027 season as a whole.

What we know now: WHO describes low global influenza activity, with regional outbreaks and differing subtype distributions. The European Centre for Disease Prevention and Control (ECDC) indicates that circulation remains low in the EU/EEA. Romania already has confirmed cases and one flu-associated death, but there are not enough data to turn these signals into a forecast for the season.

What “below 10%” means in WHO’s global influenza data

In WHO’s update No. 599, published for the week ending 4 October 2026, “below 10%” refers to the positivity rate among samples tested through surveillance systems. In other words, it is the share of tests that detected influenza virus among samples analysed by participating networks.

For more on WHO, see WHO launches global plan for dangerous high blood pressure in pregnancy, which provides additional background on the organisation.

It is not the percentage of the world’s population infected, not an individual person’s risk of catching flu, and cannot automatically be compared with a local percentage produced by a different testing system. WHO notes that countries use different surveillance methods, including sentinel networks and other forms of virological monitoring. Direct comparisons should be made cautiously.

The report nevertheless records positivity rates above 10% in some countries in Central America and the Caribbean, West Africa, and West, South, South-East and East Asia. In a few countries in South and South-East Asia, as well as isolated areas of Africa and West Asia, rates exceeded 30%.

A(H1N1)pdm09 predominates in some areas, without a uniform global increase

The wording in the headline needs to be read precisely: WHO is not describing a uniform increase in influenza worldwide. It reports that in certain areas with higher positivity, A(H1N1)pdm09 was the predominant subtype, including in East Africa, West Asia, South Asia, South-East Asia and Oceania.

Predominance is information about the composition of viruses detected. If H1N1 accounts for the largest share of positive samples in a group, that alone does not show that the absolute number of cases is rising, that the virus is causing more severe illness, or that the same pattern will emerge in Romania.

Distribution also varies by region. In Central America and the Caribbean, as well as tropical and temperate South America, WHO reported influenza B as predominant. In East Asia, A(H1N1)pdm09 and A(H3N2) were co-dominant. This variation is precisely why a global trend should not be treated as a diagnosis for every country.

Europe still has low circulation, with no clear H1N1 dominance

The available European picture was also one of an early season. For the EU/EEA and data for week 41, ECDC reported low circulation of influenza and RSV.

Among influenza samples subtyped in primary-care surveillance, A(H3) accounted for 53% and A(H1)pdm09 for 47%. In hospital reports of severe acute respiratory infections, the two subtypes were present in equal proportions, 50%–50%, from a small number of subtyped samples.

ECDC data are provisional and may be affected by reporting delays, missing countries and still-low testing volumes. They do not confirm H1N1 predominance across Europe, nor can they automatically be applied to Romania.

Romania: few confirmations, but a signal worth monitoring

According to the INSP statement for 5–11 October, republished by AGERPRES, Romania reported 82,363 acute respiratory infections. This figure includes several categories—acute upper respiratory tract infections, clinical influenza and pneumonia—and should not be presented as the number of influenza cases.

Over the same period, 201 cases of clinical influenza, 12 cases of SARI, or severe acute respiratory infection, and 12 laboratory-confirmed influenza cases were reported. The week’s confirmations included three A(H1) cases, three unsubtyped influenza A cases, three untyped cases, one influenza B case and two A+B co-infections.

INSP also announced the first death confirmed with an influenza virus in the 2026–2027 season: a man aged at least 65, from Cluj County, with pre-existing conditions. The influenza A virus was still being subtyped. It therefore cannot be said that the death was associated with A(H1N1)pdm09.

The first death is an important indicator of clinical impact, but does not by itself prove that the national season is more severe than previous ones. In the same week, the number of clinical influenza cases was lower than in the preceding week, while SARI cases increased. These indicators do not necessarily move in the same direction and require several more weeks of observation to establish a trend.

Why A(H1) reported in Romania is not automatically A(H1N1)pdm09

The terminology matters. WHO uses the full A(H1N1)pdm09 label for a specific viral subtype. INSP’s communication also includes cases labelled A(H1), but the report does not automatically establish that equivalence for every detection, and subtyping of the virus in the person who died was still under way.

Turning all such references into “H1N1 in Romania” would skip a laboratory step. The same caution applies to interpreting vaccination: the data examined here do not support conclusions about vaccine effectiveness in the current season or about an unusual change in the virus’s transmissibility.

What to watch in upcoming reports

A clearer picture will not come from a single figure. For Romania, relevant indicators will include changes in the number of tests and the positivity rate, confirmed subtypes once analyses are completed, hospital admissions and SARI cases, geographical distribution, and death reporting in its clinical context.

For readers, prevention does not depend on assuming that a particular subtype will dominate: vaccination remains an option to discuss with a doctor or pharmacist, especially for people who are eligible and those at higher risk of complications. In the event of respiratory symptoms, it is also useful to take care when using combination products: paracetamol can be present in several cold medicines, and unintentional doubling of doses should be avoided.

People experiencing difficulty breathing, persistent chest pain or pressure, confusion, severe dehydration or a rapid deterioration in their general condition should seek prompt medical assessment. These signs do not by themselves establish the cause of illness, but should not be managed only by interpreting an epidemiological report.

Frequently asked questions

Does global positivity below 10% mean fewer than 10% of people have flu?

No. Positivity is the proportion of samples tested through surveillance systems that are positive for influenza. It is not a direct estimate of the share of the population infected.

Does A(H1N1)pdm09 predominance mean the season will be more severe?

No. Predominance describes the distribution of subtypes among detected viruses. By itself, it does not demonstrate a rise in case numbers, greater severity or a higher risk for Romania.

Was H1N1 confirmed in the person who died in Romania?

No. INSP said the person had been confirmed with influenza A and that subtyping was under way. The virus should not automatically be identified as A(H1N1)pdm09.

Why can’t WHO data be compared directly with data from Romania?

Because they cover different systems, periods and indicators. WHO provides a global surveillance picture, while INSP reports national indicators including respiratory infections, clinical influenza, laboratory confirmations and SARI.

Sources consulted

Etichete: A(H1N1)pdm09ECDCfluINSPWHOpublic healthRespiratory viruses
Share this article
COMUNITATEA INFOBUZ

Discuția cititorilor

Ai o opinie sau o întrebare despre acest articol? Spune-ne ce crezi.

0 comentarii

Fii primul care deschide discuția.

Lasă un comentariu

Email address este vizibilă doar administratorilor și nu va fi publicată. Câmpurile marcate cu * sunt obligatorii.

Te rugăm să păstrezi un limbaj civilizat și să discuți la subiect. Comentariile spam sunt filtrate automat.